MarketsStocksGVBL
GV

Genomic Valley Biotech Ltd

NSE: GVBLBSE: 539206Healthcare
26.01
-2.00%
NSE · 15-min delayed
Mkt Cap
₹8 Cr
P / E
221.2
P / B
2.1
ROE
0.8%
52W High
₹54.27
52W Low
₹20.10
Key Metrics
Market Cap
₹8 Cr
P / E
221.2
P / B
2.1
ROCE
1.0%
ROE
0.8%
Div Yield
-
Revenue · ₹ Cr
1
FY20
0
FY21
0
FY22
3
FY23
0
FY24
1
FY25
0
FY26
Net Profit · ₹ Cr
0
FY20
-1
FY21
0
FY22
1
FY23
0
FY24
0
FY25
0
FY26
EPS · ₹ per share
₹0.9
FY20
₹-1.8
FY21
₹-0.0
FY22
₹2.1
FY23
₹0.1
FY24
₹1.2
FY25
₹0.1
FY26
Q1 2026 snapshot
Sales
₹0 Cr
Operating profit
-
OPM
-
Net profit
₹-0 Cr
EPS
-
Scorecard · 7 axes
Quality
Weak
35/100
Valuation
Bad
221.2×
Growth
Bad
-1.7%
Profitability
Bad
0.9%
Performance
Bad
-43.8%
Entry Point
Strong
48%
Red Flags
Strong
0 flags
Shareholding Pattern
46.1%Promoter
Promoter46.1%
Public53.9%
Quarterly Results · ₹ Cr
QuarterFY21 06QFY21 09QFY21 12QFY22 03QFY22 09QFY24 03Q
Revenue1,69,6002,89,8002,46,20055,5002,05,0000
Net Profit-0.109-5,71,7001,08,5000.1466,14,700-0.045
NPM %-0.0%-197.3%44.1%0.0%299.9%-
AlertPre-trade